Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trialFei Ma, Binghe Xu, Zhongsheng Tong et al.|BMJ|2023Cited by 82
Cardioprotective potentials of myricetin on doxorubicin-induced cardiotoxicity based on biochemical and transcriptomic analysisJaili Li, Xingjiang Qi, Ting Luo et al.|Biomedicine & Pharmacotherapy|2024Cited by 14